Millipore Sigma Vibrant Logo

481908 Nicotinamide Phosphoribosyltransferase Inhibitor, FK866 - CAS 658084-64-1 - Calbiochem

The Nicotinamide Phosphoribosyltransferase Inhibitor, FK866, also referenced under CAS 658084-64-1, controls the biological activity of Nicotinamide Phosphoribosyltransferase. This small molecule/inhibitor is primarily used for Neuroscience applications.

Nicotinamide Phosphoribosyltransferase Inhibitor, FK866 - CAS 658084-64-1 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: NAPRT Inhibitor, (E)-N-(4-(1-Benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide, NAMPT Inhibitor, APO866, NAMPTase Inhibitor I, PBEF Inhibitor I, Visfatin Inhibitor I

View This Product on Sigma-Aldrich
481908
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
658084-64-1C₂₄H₂₉N₃O₂

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
481908-2MGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 2 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell-permeable pyridinylacrylamide compound that acts as a selective, allosteric NAPRT/NAMPT (nicotinamide phosphoribosyltransferase) inhibitor (Ki = 0.4 nM for the enzyme/substrate complex; Ki′ = 0.3 nM for the free enzyme), while exhibiting no effect toward NPRT (nicotinic acid phosphoribosyltransferase) activity (82% inhibition of NAPRT activity at 10 nM vs no inhibition of NPRT activity at 1 µM in K-562 extract). FK866 treatment is shown to induce cell death by depleting NAD+ (Cat. Nos. 481911 & 481915) in HepG2 and NIH-3T3 cultures (by >95% after 24 h treatment of 10 nM FK866), likewise the addition of exogenous NAD+ is demonstrated to rescue NIH-3T3 and SH-SY5Y from FK866-induced NAD+-depletion and cell death.
      Catalogue Number481908
      Brand Family Calbiochem®
      SynonymsNAPRT Inhibitor, (E)-N-(4-(1-Benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide, NAMPT Inhibitor, APO866, NAMPTase Inhibitor I, PBEF Inhibitor I, Visfatin Inhibitor I
      References
      ReferencesFormentini, L., et al. 2009. Biochem. Pharmacol. 77, 1612.
      Nakahata, Y., et al. 2009. Science 324, 654.
      Ramsey. K.M., et al. 2009. Science 324, 651.
      Billington, R.A., et al. 2008. J. Biol. Chem. 283, 6367.
      Hasmann, M. and Schemainda, I., 2003. Cancer Res. 63, 7436.
      Product Information
      CAS number658084-64-1
      FormColorless to yellow liquid
      FormulationSupplied as a 50 mM (2 mg/102.17 µl) solution in DMSO.
      Hill FormulaC₂₄H₂₉N₃O₂
      Chemical formulaC₂₄H₂₉N₃O₂
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥97% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      481908-2MGCN 04055977225532

      Documentation

      Nicotinamide Phosphoribosyltransferase Inhibitor, FK866 - CAS 658084-64-1 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Nicotinamide Phosphoribosyltransferase Inhibitor, FK866 - CAS 658084-64-1 - Calbiochem 試験成績書（CoA）

      タイトルロット番号
      481908

      参考資料

      参考資料の概要
      Formentini, L., et al. 2009. Biochem. Pharmacol. 77, 1612.
      Nakahata, Y., et al. 2009. Science 324, 654.
      Ramsey. K.M., et al. 2009. Science 324, 651.
      Billington, R.A., et al. 2008. J. Biol. Chem. 283, 6367.
      Hasmann, M. and Schemainda, I., 2003. Cancer Res. 63, 7436.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-May-2020 JSW
      SynonymsNAPRT Inhibitor, (E)-N-(4-(1-Benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide, NAMPT Inhibitor, APO866, NAMPTase Inhibitor I, PBEF Inhibitor I, Visfatin Inhibitor I
      DescriptionA cell-permeable pyridinylacrylamide compound that acts as a selective, allosteric NAPRT/NAMPT (nicotinamide phosphoribosyltransferase) inhibitor (Ki = 0.4 nM for the enzyme/substrate complex; Ki′ = 0.3 nM for the free enzyme), while exhibiting no effect toward NPRT (nicotinic acid phosphoribosyltransferase) activity (82% inhibition of NAPRT activity at 10 nM vs no inhibition of NPRT activity at 1 µM in K-562 extract). FK866 treatment is shown to induce cell death by depleting NAD+ (Cat. Nos. 481911 & 481915) in HepG2 and NIH-3T3 cultures (by >95% after 24 h treatment of 10 nM FK866), likewise the addition of exogenous NAD+ is demonstrated to rescue NIH-3T3 and SH-SY5Y from FK866-induced NAD+-depletion and cell death.
      FormColorless to yellow liquid
      FormulationSupplied as a 50 mM (2 mg/102.17 µl) solution in DMSO.
      Intert gas (Yes/No) Packaged under inert gas
      CAS number658084-64-1
      Chemical formulaC₂₄H₂₉N₃O₂
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (100 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Toxicity Standard Handling
      ReferencesFormentini, L., et al. 2009. Biochem. Pharmacol. 77, 1612.
      Nakahata, Y., et al. 2009. Science 324, 654.
      Ramsey. K.M., et al. 2009. Science 324, 651.
      Billington, R.A., et al. 2008. J. Biol. Chem. 283, 6367.
      Hasmann, M. and Schemainda, I., 2003. Cancer Res. 63, 7436.